Ionis Pharmaceuticals, Inc.
MODULATION OF HUNTINGTIN EXPRESSION
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of huntingtin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate Huntington's disease, or a symptom thereof.
Status:
Application
Type:
Utility
Filling date:
8 Feb 2019
Issue date:
15 Aug 2019